Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2025 Earnings Call Transcript November 5, 2025
Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-1.17427 EPS, expectations were $-0.7.
Operator: Hello, and welcome to Vir Biotechnology’s Third Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded. [Operator Instructions] I will now turn the call over to Jason O’Byrne, Chief Financial Officer. Please go ahead.
Jason...
